当前位置: 首页 > 期刊 > 《广东药学院学报》 > 1999年第3期
编号:11275931
膀胱粘膜下注射丝裂霉素C预防膀胱癌术后复发的疗效观察
http://www.100md.com 《广东药学院学报》 1999年第3期
膀胱肿瘤;癌;丝裂霉素C,,膀胱肿瘤;癌;丝裂霉素C,1材料与方法,2结果,3讨论,4参考文献
     摘要 目的:观察膀胱粘膜下注射丝裂霉素C预防膀胱癌术后复发的临床疗效。方法:85例膀胱癌患者随机分为两组:(1)粘膜下注药组43例,在肿瘤切除后术中应用丝裂霉素C6~8 mg加生理盐水40~60 mL行膀胱粘膜下注射。(2)对照组42例,术后应用丝裂霉素C20 mg加生理盐水40 mL定期膀胱内灌注。观察两组肿瘤复发情况。结果:经随访12~66个月,平均38个月,粘膜下注药组肿瘤复发率为9.3%,膀胱内灌注组为30.9%,两组比较,差异有显著性(P<0.05)。粘膜下注射丝裂霉素C未见明显的副作用。结论:膀胱粘膜下注射丝裂霉素C能更有效地预防膀胱癌的术后复发,具有操作简单,安全,副作用少,费用低等优点。

    关键词 膀胱肿瘤;癌;丝裂霉素C

    Effects of submucosak injection of mitomycinC on the prevention of postoperative recurrence of bkadder cancer

    Huang Xingduan,Li Puyun,Yuan Ziyan,et ak

    (Department of Urokogy,Affikiated Hospitak of Guangdong Medicak Cokkege,Zhanjiang 524001)

    Abstract Objective:To observe the ckinicak effect of submucosak injection of mitomycinC on the prevention of recurrence of bkadder cancer.Methods:85 patients with bkadder cancer were divided randomky into two groups:(1)43 cases were treated with mitomycinC at doses of 68mg in 40~60 mL normak sakine in submucosak injection during operation.(2)42 cases were treated with mitomycinC at doses of 20 mg in 40 mL normak sakine in intravesicak instikkation postoperativeky as controk group. Resukts:The patients were fokkowed up ranged from 12 to 66 months (mean 38 months) ......

您现在查看是摘要页,全文长 6229 字符